Equitable Holdings’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Sell
7,495
-13,105
-64% -$638K ﹤0.01% 1412
2026
Q1
$903K Buy
20,600
+6,060
+42% +$261K 0.01% 1015
2025
Q4
$637K Buy
14,540
+2,305
+19% +$95.4K ﹤0.01% 1029
2025
Q3
$505K Buy
+12,235
New +$492K ﹤0.01% 1070

Other funds holding EXEL

Equitable Holdings's EXEL Position: Q2 2026 in Review

Equitable Holdings reduced its Exelixis (EXEL) stake by 64% in Q2 2026, selling an estimated $638K and leaving 7,495 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Equitable Holdings first reported a position in EXEL in Q3 2025 and has held it in 4 quarters since. The position peaked at $903K in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Equitable Holdings held 7,495 shares of Exelixis worth $408K as of Q2 2026.
  • Equitable Holdings sold 13,105 Exelixis shares in Q2 2026, an estimated $638K.
  • Exelixis made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1412 holding.
  • Equitable Holdings first reported a position in Exelixis in Q3 2025 and has held it in 4 quarters since.
  • Equitable Holdings's Exelixis position peaked at $903K in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.